RXO closed at $27.88 on Nov 5, down 1.83%, 4.8% below its 52-week closing high. Volume of 4.9M shares was 1.31× its 20-day average (above normal).
Split-adjusted performance: -1.7% over one month, +20.6% over six months, +60.4% over one year.
In the quarter ended Sep 30, 2026, revenue was $1.87B, up 31.7% from a year earlier, with a net margin of 0.2%.
Short interest was 10.8M shares at the Oct 15 settlement, down 24.9% from the prior report (6.6% of float, 1.8 days to cover).